10 Best Income Stocks For 2014

New products and changes introduced over the last week include two mutual funds from Schroders and an emerging markets fund from OppenheimerFunds.

Also, NASDAQ OMX has launched a REIT benchmark-index family, and former Goldman Sachs trader Adam Grealish has launched a financial/tech job search service.

Here are the latest developments of interest to advisors:

1) Schroders Adds Two Funds

Schroders has announced the launch of the Schroder Global Multi-Asset Income Fund (SGMNX) and the Schroder Global Strategic Bond Fund (SGBNX).

SGMNX is a diversified portfolio that seeks to maximize income and manage volatility by investing directly into both equities and fixed income securities around the globe. Its benchmark is unconstrained, which enables the team to be flexible in its search for the best risk-adjusted income opportunities across regions, asset classes and sectors.

SGBNX is an actively managed portfolio with the flexibility to invest in the best opportunities throughout the fixed income universe. It enables investors to invest tactically and strategically across the whole spectrum of global fixed income sectors, regions, asset classes and FX.

Top Healthcare Equipment Companies To Watch In Right Now: RigNet Inc.(RNET)

RigNet, Inc. provides remote communications services for the oil and gas industry. It offers remote communications services through a controlled and managed Internet protocol/multiprotocol label switching (IP/MPLS) global network, enabling drilling contractors, oil companies, and oilfield service companies to communicate. The company offers a communications package of voice, data, video, networking, and real-time data management to offshore and land-based remote locations. It primarily provides voice-over-Internet-protocol, data, and high-speed Internet access, as well as other value-added services, such as video conferencing solutions, TurboNet solutions for wide area network, real-time data management solutions, Wi-Fi hotspots and Internet kiosks, wireless intercoms, and handheld radios. The company also offers Secure Oil Information Link, a managed members-only communications network hub that enables collaborative partners, suppliers, and customers to transfer and share data. It serves the owners and operators of offshore drilling rigs and production facilities, land rigs, remote offices, and supply bases primarily in the United States, Brazil, Norway, the United Kingdom, Nigeria, Qatar, Saudi Arabia, Singapore, and Australia. The company was founded in 2000 and is headquartered in Houston, Texas.

Advisors' Opinion:

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on RigNet (Nasdaq: RNET  ) , whose recent revenue and earnings are plotted below.

10 Best Income Stocks For 2014: Sarepta Therapeutics Inc (SRPT)

Sarepta Therapeutics Inc., formerly AVI BioPharma, Inc., incorporated on July 22, 1980, biopharmaceutical company focused on the discovery and development of ribonucleic acid (RNA)-based therapeutics for the treatment of rare and infectious diseases. The Company�� product candidates include Eteplirsen, AVI-6002, AVI-6003, and AVI-7100. As of December 31, 2011, the Company primarily focused on advancing the development of its Duchenne muscular dystrophy drug candidates, including its lead product candidate, eteplirsen, which is in a Phase IIb trial. The Company is also focused on developing therapeutics for the treatment of infectious diseases, including its lead infectious disease programs aimed at the development of drug candidates for the Ebola and Marburg hemorrhagic fever viruses. The Company's program focuses on the development of disease-modifying therapeutic candidates for Duchenne muscular dystrophy (DMD). The Company initiated a Phase IIb trial for eteplirsen in August 2011 with an objective of initiating a pivotal trial subsequent to 2011.

The Company is also leveraging the capabilities of its RNA-based technology platforms to develop therapeutics for the treatment of infectious diseases. The Company's RNA-based drug programs are clinically evaluated for the treatment of DMD and have also demonstrated anti-viral activity in infectious diseases such as Ebola, Marburg and H1N1 influenza in certain animal models. The Company's lead product candidates are at various stages of development.

Duchenne Muscular Dystrophy Program

The Company's lead program is designed to address specific gene mutations that result in DMD by forcing the genetic machinery to skip over an adjacent contiguous piece of RNA and, thus, restore the ability of the cell to express a new, truncated but functional, dystrophin protein.

Eteplirsen is an antisense PMO-based therapeutic in clinical development for the treatment of individuals with DMD who have an error in the gene codi! ng for dystrophin that can be treated by skipping exon 51. Eteplirsen targets the frequent series of mutations that cause DMD. Eteplirsen has been granted orphan drug designation in the United States and European Union. In addition to the Company's lead product candidate, eteplirsen, the Company is actively pursues development of a product candidate that skips exon 45 through an IND-enabling collaboration.

Anti-Viral Programs

The Company is implementing its RNA-based technology platforms in its anti-viral programs for the development of therapeutics to treat viruses, such as Ebola, Marburg and influenza. The Company's arrangement with DoD supporting the development of the Company's Ebola and Marburg virus drug candidates provides funding for all clinical and licensure activities necessary to obtain approval of a New Drug Application (NDA), by the United States Food and Drug Administration (FDA), if DoD exercises all of its options under the arrangement. During the year ended December 31, 2011, the Company paused its clinical development efforts on AVI-7100 and is exploring funding opportunities or partnerships with DHHS and industry collaborators to advance its development.

The Company's anti-viral therapeutic programs use the Company's translation suppression technology and applies its PMOplus chemistry backbone, an advanced generation of its base PMO chemistry backbone that selectively introduces positive backbone charges to improve selective interaction between the drug and its target. The Company's translation suppressing technology is based on Translation Suppressing Oligomers (TSOs), which are PMO-based compounds that stop or suppress the translation of a specific protein by binding to their specific target sequence in mRNA.

The Company is pursuing development and regulatory approval of its Ebola and Marburg hemorrhagic fever virus product candidates under the FDA's Animal Rule. The Company's lead product candidate against the Ebola virus infec! tion is A! VI-6002. For Marburg virus infection, the Company's lead product candidate has been AVI-6003. In February 2012, the Company announced that the Company received approval from the FDA to remove one of the two oligomers composing AVI-6003 and proceed with a single oligomer approach, AVI-7288, given that efficacy in non-human primates has been demonstrated to be attributable to this single oligomer. The Company is exploring the feasibility of alternate routes of administration of its Ebola and Marburg drug candidates, and at DoD's invitation, the Company is developing a proposal to be submitted for a study to demonstrates feasibility of the intramuscular route.

AVI-6002, which is a combination of AVI-7537 and AVI-7539, is designed for post-exposure prophylaxis after documented or suspected exposure to the Ebola virus. The Company is evaluating the feasibility of developing AVI-7537 as a single agent for the post-exposure prophylaxis after documented or suspected exposure to Ebola virus. AVI-6003, which is a combination of AVI-7287 and AVI-7288, is designed for post-exposure prophylaxis after documented or suspected exposure to Marburg virus. In February 2012, the Company announced that the Company received approval from the FDA to proceed with AVI-7288 as a single agent against Marburg virus infection. The Company intends to proceed with dosing AVI-7288 in the Phase I multiple ascending dose studies and in non-human primate studies.

Influenza Program

The Company's anti-viral therapeutic programs are also focused on the development of the Company's product candidates designed to treat pandemic influenza viruses. AVI-7100 is the Company's lead product candidate for the treatment of influenza and employs its PMOplus technology. In June 2011, the Company initiated dosing of AVI-7100 through intravenous infusion in single-ascending doses in up to 48 healthy adult volunteers. As of December 31, 2011, the Company paused its clinical development efforts on AVI-7100 and are exp! loring fu! nding opportunities or partnerships to advance its development.

The Company has developed three new phosphorodiamidate-linked morpholino oligomers (PMO)-based chemistry platforms in addition to its original PMO-based technology. The Company's PMO-based molecules are designed to sterically block the access of cellular machinery to pre-mRNA and mRNA without degrading the RNA. Through this selective targeting, two distinct biologic mechanisms of action can be initiated: modulation of pre-mRNA splicing and inhibition of mRNA translation.

The Company competes with GlaxoSmithKline plc, Toyama Chemical, Alnylam Pharmaceuticals, Inc., Tekmira Pharmaceuticals Corp., Isis Pharmaceuticals, Inc., Prosensa, and Santaris Pharma A/S.

Advisors' Opinion:

• [By Jayson Derrick]

  The FDA's Center for Drug Evaluation and Research stated that the agency is exploring potential pathways to approve new drugs that could be used to treat Duchenne muscular dystrophy. Specifically, Sarepta Therapeutics' (NASDAQ: SRPT) eteplirsen was mentioned as potentially being placed in an accelerated approval program. Shares gained 12.79 percent, closing at $22.93.

• [By Rich Bieglmeier]

  It's not every day that a stock is up 40% but still might have another 50%+ to go. However, that is the case with Sarepta Therapeutics Inc. (NASDAQ:SRPT).

• [By John Udovich]

  On Thursday, small cap Sarepta Therapeutics Inc (NASDAQ: SRPT) surged 40.14% after�announcing that its Duchenne muscular dystrophy drug eteplirsen had continued to help patients after more than two years of treatment, meaning its time to take a closer look at the stock along with potential performance benchmarks like the iShares NASDAQ Biotechnology Index ETF (NASDAQ: IBB) and SPDR S&P Biotech ETF (NYSEARCA: XBI) plus the troubles another biotech has had with its DMD drug.

• [By Ben Levisohn]

  Shares of Sarepta Therapeutics (SRPT) and Plug Power (PLUG) are falling in after-hours trading after the two companies announced plans to sell more shares.

  Sarepta Therapeutics said it plans to sell as much as $100 million in new shares and also granted underwriters a 30-day option to buy as much as $15 million more. Plug Power announced a sale, but said the amount would depend on “market and other conditions.”

  Shares of Sarepta Therapeutics have fallen 4.5% to $38.79 at 4:49 p.m. in after-hours trading, while Plug Power has tumbled 8.7% to $6.12.

10 Best Income Stocks For 2014: Qatar Investment Fund PLC (QIF)

Qatar Investment Fund plc, formerly Epicure Qatar Equity Opportunities plc, is a closed-end investment company established to invest primarily in quoted equities of Qatar and other Gulf Co-operation Council (GCC) countries. Its investment objective is to capture, principally through the medium of the Qatar Exchange by investing in listed companies or companies to be listed. It also invests in listed companies, pre-initial public offer (IPO) companies, in other GCC countries. As of June 30, 2010, the Company had a portfolio of 22 investments in quoted companies in the Gulf, with 17 of them being in Qatar, four investments in United Arab Emirates and one in Kuwait. As at June 30, 2010, the top five holdings of the Company are Qatar National bank, Industries Qatar, Commercial Bank of Qatar, Qatar Islamic Bank and Rayan Bank. The Company�� wholly owned subsidiary is Epicure Qatar Opportunities Holdings Limited. The investment manager of the Company is Epicure Managers Qatar Limited. Advisors' Opinion:

• [By Vivian Lewis]

  The fund also operates to cut tax liabilities. EXG executes timely trades to capture additional qualified dividend income (QIF) subject to capital gains taxes which are usually lower than income taxes.

10 Best Income Stocks For 2014: Home Properties Inc. (HME)

Home Properties, Inc. is an independent real estate investment trust. The firm invests in the real estate markets of the United States. It is engaged in the ownership, management, acquisition, rehabilitation and development of residential apartment communities. The firm also invests in townhomes and offices. Home Properties, Inc. was founded in November 1993 and is based in Rochester, New York.

Advisors' Opinion:

• [By Marc Bastow]

  Apartment community real estate investment trust (REIT) Home Properties (HME) raised its quarterly dividend 4.3% to 73 cents per share, payable on Feb. 25 to shareholders of record as of February 13. At a 5% yield, HME is the highest yielder of this week’s list of dividend stocks increasing payouts.
  HME Dividend Yield: 5.00%

10 Best Income Stocks For 2014: GP Strategies Corp (GPX)

GP Strategies Corporation (GP Strategies), incorporated in 1966, is a global performance improvement solutions provider of sales and technical training, e-learning solutions, management consulting and engineering services. The Company operates in five segments: Learning Solutions, Professional & Technical Services, Sandy Training & Marketing, RWD and Energy Services. Its clients include companies and governmental and other commercial customers in a variety of industries. It serves companies in the automotive, steel, oil and gas, power, chemical, electronics and technology, manufacturing, software, financial, retail, healthcare and food and beverage industries, as well as government agencies. On December 31, 2011, GP Strategies Corporation merged with and into its operating subsidiary, General Physics Corporation (General Physics). On August 1, 2011, the Company acquired TK Holdings Ltd and its subsidiary Beneast Training Ltd. In September 2012, the Company acquired Rovsing Dynamics. In October 2012, it acquired BlessingWhite. In June 2013, the Company announced that it has acquired Prospero Learning Solutions. In June 2013, GP Strategies Corp announced that it has acquired Lorien Engineering Solutions (LES).

On April 15, 2011, the Company acquired the consulting business of RWD Technologies, LLC (RWD). On April 1, 2011, the Company acquired Ultra Training Ltd. On February 1, 2011, through its wholly owned subsidiaries in Hong Kong and Shanghai, the Company acquired the training business and certain related assets of Cathay/Communication Consulting Limited. The Company conducts its business outside of the United States in over 40 countries primarily through its wholly owned subsidiaries located in the United Kingdom, France, Germany, Canada, Mexico, Colombia, Singapore, China and India. As of December 31, 2011, the Company operates in five segments: Learning Solutions, Professional & Technical Services, Sandy Training & Marketing (Sandy), RWD and Energy Services. On October 1, 2011, the C! ompany made two management reporting changes, which resulted in a change to its segments. The Learning Solutions group and the Europe group, which were both formerly part of the Manufacturing & BPO segment are aggregated into a separate segment named Learning Solutions. In addition, the Manufacturing group, which was also part of the Manufacturing & BPO segment, assumed management responsibility for the former Process & Government group and this newly combined group is a separate reportable segment named Professional & Technical Services.

The Company offers a range of training business process outsourcing (BPO) services, including design, delivery and global management of comprehensive learning programs, to national and multinational businesses and government organizations and can deliver its services individually or as a complete, integrated training solution. The Company�� consulting, engineering, and technical support services range from traditional business consulting, which include lean enterprise consulting services, to specialized engineering and technical support services, such as design and evaluation services regarding facilities, processes and systems. The Company�� consulting and engineering customers typically operate in industries, such as oil and gas, power, chemical, aerospace, transportation and manufacturing industries, and include customers, such as Pratt & Whitney, General Dynamics Corporation, Rockwell Automation, Luminant Energy, NRG Energy and Ameren Energy.

Learning Solutions

The Learning Solutions segment delivers training, curriculum design and development, e-Learning services, system hosting, training business process outsourcing and consulting services primarily to companies in the electronics and semiconductors, healthcare, software, financial and other industries as well as to government agencies. This segment�� ability to deliver a range of training services on a global basis allows it to take over the entire learning function f! or the cl! ient, including their training personnel.

Professional & Technical Services

The Professional & Technical Services segment is engaged in providing training, consulting, engineering and technical services, including lean consulting, emergency preparedness, safety and regulatory compliance, chemical demilitarization and environmental services primarily to companies in the manufacturing, steel, pharmaceutical and petrochemical industries, federal and state government agencies and government contractors. This segment also provides services to users of alternative fuels, including designing and constructing liquefied natural gas (LNG) and hydrogen fueling stations, as well as supplying fuel and equipment.

Sandy Training & Marketing

The Sandy segment provides custom product sales training and serving manufacturing customers in the United States automotive industry. Sandy provides custom product sales training designed to better educate customer sales forces with respect to new vehicle features and designs, in effect rapidly increasing the sales force knowledge base and enabling them to address detailed customer queries. In addition, Sandy helps its clients assess their customer relationship marketing (CRM) strategy, measure performance against competitors and connect with their customers on a one-to-one basis. This segment also provides technical training services to automotive customers.

RWD

The RWD segment provides human capital management and information technology (IT) consulting services, end user training, change management, knowledge management and operator effectiveness management solutions. The Segment operates in industries, such as manufacturing, aerospace, healthcare, life sciences, consumer products, financial, telecommunications, services and higher education, as well as the public sector.

Energy Services

The Energy Services segment provides engineering services, products and training primarily! to elect! ric power utilities. The Company�� EtaProTM Performance Monitoring and Optimization System provides a suite of performance solutions for power generation plants and is installed at approximately 900 power generating units in over 30 countries. In addition to providing custom training solutions, this segment provides Web-based training through its GPiLearn portal to over 30,000 power plant personnel in the United States and in over 40 countries.

The Company provides custom training services and products to support existing, as well as the launch of new, plants, products, equipment, technologies and processes. The range of services includes fundamental analysis of a client�� training needs, curriculum design, instructional material development (in hard copy, electronic/software or other format), information technology service support and delivery of training. Training products include custom instructor and student training manuals, and instructional materials suitable for Web-based and blended learning solutions. The Company�� instructional delivery capabilities include traditional classroom, structured on-the-job training (OJT), just-in-time methods, computer-based, Web-based, video-based and the spectrum of e-Learning technologies.

The Company provides end-to-end business process outsourcing solutions, including the management of its customers training departments, as well as administrative processes, such as tuition assistance program management, vendor management, call center / help desk administration and learning management system (LMS) administration. The Company�� training BPO services encompass a spectrum of learning engagements from transactional multi-week assignments focused on a single aspect of a learning process to multi-year contracts where it manages the learning infrastructure of its customer. In addition, the Company automates a huge amount of its customers tuition reimbursement programs by utilizing its own software.

The consulting servi! ces inclu! de not only training-related consulting services, but also traditional business management, engineering and other disciplines. The Company also provides engineering consulting services to support regulatory and environmental compliance, modification of facilities and processes, plant performance improvement, reliability-centered maintenance practices and plant start-up activities. Consulting services also include IT consulting and enterprise resource planning (ERP) implementation services, operations continuity assessment, planning, training and procedure development. Consulting products include training and reference materials.

The technical support services include procedure writing and configuration control for capital intensive facilities, plant start-up assistance, logistics support (inventory management and control), implementation and engineering assistance for facility or process modifications, facility management for high technology training environments, staff augmentation and help-desk support for standard and customized client desktop applications. Technical support products include the Company�� EtaPRO and Virtual Plant software applications that serve the power generation industry.

Advisors' Opinion:

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on GP Strategies (NYSE: GPX  ) , whose recent revenue and earnings are plotted below.

10 Best Income Stocks For 2014: CSB Bancorp Inc (CSBB)

CSB Bancorp, Inc. (CSB), incorporated in 1991, is a financial holding company. The Commercial and Savings Bank of Millersburg, Ohio (the Bank) is a wholly owned subsidiary of the Company. CSB operates primarily through the Bank and its other subsidiaries, providing a range of banking, trust, financial and brokerage services to corporate, institutional and individual customers throughout northeast Ohio. The Bank provides retail and commercial banking services to its customers, including checking and savings accounts, time deposits, individual retirement accounts (IRAs), safe deposit facilities, personal loans, commercial loans, real estate mortgage loans, installment loans, night depository facilities, brokerage and trust services.

Lending Activities

The Bank provides residential real estate, commercial real estate, commercial and consumer loans to customers located primarily in Holmes, Tuscarawas, Wayne, Stark and portions of surrounding counties in Ohio. Commercial loan rates are variable as well as fixed, and include operating lines of credit and term loans made to small businesses, primarily based on their ability to repay the loan from the cash flow of the business. Business assets, such as equipment, accounts receivable and inventory typically secure such loans. Commercial real estate loans are primarily secured by borrower-occupied business real estate. Commercial real estate loans are generally originated with a loan-to-value ratio of 80% or less. Commercial construction loans are secured by commercial real estate and in most cases the Bank also provides the permanent financing. Residential real estate loans carry both fixed and variable rates and are secured by the borrower�� residence. Home equity lines of credit are made to individuals and are secured by second or first mortgages on the borrower�� residence. Installment loans to individuals include loans secured by automobiles and other consumer assets, including second mortgages on personal residences.

Investment Activities

As of December 31, 2011, the Company�� securities available-for-sale totaled $123,026,000. Its portfolio of securities available-for-sale includes the United States treasury securities, the United States Government corporations and agencies, mortgage-backed securities, obligations of states and political subdivisions, equity securities, and corporate bonds.

Sources of Funds

As of December 31, 2011, the Company�� portfolio of deposits included noninterest-bearing demand, interest-bearing demand deposits, savings deposits and time deposits. Short-term borrowings consist of securities sold under agreements to repurchase, short-term advances through Federal Home Loan Bank and federal funds purchased.

Advisors' Opinion:

• [By CRWE]

  Today, CSBB remains (0.00%) +0.000 at $18.75 thus far (ref. google finance Delayed: 3:53PM EDT July 30, 2013).

  CSB Bancorp, Inc. previously reported second quarter 2013 net income of $1.25 million or $.45 per basic and diluted share, as compared to $1.14 million or $.41 per basic and diluted share for the same period in 2012.

  Annualized returns on average common equity (��OE�� and average assets (��OA�� for the quarter were 9.32% and 0.88%, respectively, compared with 8.98% and 0.82% for the second quarter of 2012.

  Eddie Steiner, President and CEO commented, ��e continue to focus on growing relationships with current and new customers. The bank�� average loan balances have increased 10% in the past year, and although margins remain tight, this growth has provided increases of approximately 4% in net interest income.��/p>

10 Best Income Stocks For 2014: R.G. Barry Corporation(DFZ)

R.G. Barry Corporation, together with its subsidiaries, engages in designing, sourcing, marketing, and distributing consumer products in the retail accessories category primarily in North America. It operates in two segments, Footwear and Accessories. The Footwear segment offers footwear products comprising primarily slippers, sandals, hybrid and fashion footwear, slipper socks, and hosiery under the Dearfoams, Angel Treads, DF by Dearfoams, Utopia by Dearfoams, and Terrasoles names. This segment also markets Levi?s branded slippers and sandals. The Accessories segment provides foot and shoe care products, such as cushioned insoles, handbags, tote bags, and travel products for women under the Foot Petals, Fab Feet, Glamour Toez, Heavenly Heelz, Killer Kushionz, baggallini, and Le Bagg names. The company markets its products through accessory sections of department stores, chain stores, warehouse clubs, specialty stores, independent stores, television shopping networks, e- tailing/Internet based retailers, discount stores, and mass merchandising channels of distribution. R.G. Barry Corporation was founded in 1947 and is headquartered in Pickerington, Ohio.

Advisors' Opinion:

• [By Marc Bastow]

  Brand development and marketing products provider R.G. Barry (DFZ) raised its quarterly dividend 11.1% to 10 cents per share, payable on Apr. 4 to shareholders of record as of Feb. 17.
  DFZ Dividend Yield: 2.25%